A Randomized Controlled Trial for 'Huoxue Tongluo Decoction' in Treating Erectile Dysfunction of Blood Stasis and Kidney Deficiency

Not Applicable

Recruiting

• Conditions: Male erectile dysfunction

• Registration Number: ITMCTR1900002469
• Lead Sponsor: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

1 meet the diagnostic criteria of impotence (erectile dysfunction) Western medicine;
2 meet the diagnostic criteria of impotence-blood stasis and kidney deficiency syndrome;
3 male, aged 20 to 69 years, have the same conditions, normal sexual desire;
4 IIEF-5<21 points;
5 The course of disease is >= 12 weeks;
6 people who have voluntarily signed informed consent.

Exclusion Criteria

1 Allergic constitution and those who are allergic to experimental drugs;
2 Patients with renal cancer, bladder tuberculosis, and urinary calculi;
3 Combined with other malignant tumor patients;
4 Patients with blood system diseases, coagulopathy and autoimmune diseases;
5 Combined with severe cardiovascular disease, cerebrovascular disease, hematopoietic system disease, neuropathic patients;
6 Participated in other clinical researchers 3 months before the trial.
For the above 6 exclusion criteria, as long as one of the criteria is met, the exclusion criteria are met and need to be excluded.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
international index of erectile function, IIEF-5;

Secondary Outcome Measures

Name	Time	Method
TCM syndrome score;